Single photon-emission computed tomography imaging in early Parkinson's disease

Angelo Antonini, Ioannis U. Isaias

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Current diagnostic criteria for Parkinson's disease (PD) rely on the presence of motor signs, but it is now evident that they require months or years to become clinically manifest. By contrast, initial manifestations of PD may involve several nonmotor domains, such as cognition, mood, smell or sleep, and their recognition is critical if one is aiming for early diagnosis to provide neuroprotection. In this context, imaging tracers are gaining relevance as they are increasingly recognized as biological markers of disease progression. In this review, we will discuss the role of single photon-emission computed tomography imaging in the early phases of PD and in the differential diagnosis of essential tremor and atypical parkinsonism. We will also discuss the role of imaging of monoaminergic nondopamine systems to assess nonmotor features.

Original languageEnglish
Pages (from-to)1853-1864
Number of pages12
JournalExpert Review of Neurotherapeutics
Volume8
Issue number12
DOIs
Publication statusPublished - Dec 2008

Fingerprint

Single-Photon Emission-Computed Tomography
Parkinson Disease
Essential Tremor
Smell
Parkinsonian Disorders
Cognition
Disease Progression
Early Diagnosis
Sleep
Differential Diagnosis
Biomarkers

Keywords

  • Dopamine transporter
  • Essential tremor
  • Parkinson's disease
  • Perfusion tracer
  • SPECT

ASJC Scopus subject areas

  • Clinical Neurology
  • Pharmacology (medical)
  • Neuroscience(all)

Cite this

Single photon-emission computed tomography imaging in early Parkinson's disease. / Antonini, Angelo; Isaias, Ioannis U.

In: Expert Review of Neurotherapeutics, Vol. 8, No. 12, 12.2008, p. 1853-1864.

Research output: Contribution to journalArticle

Antonini, Angelo ; Isaias, Ioannis U. / Single photon-emission computed tomography imaging in early Parkinson's disease. In: Expert Review of Neurotherapeutics. 2008 ; Vol. 8, No. 12. pp. 1853-1864.
@article{32a91f5c5aff48108e48328ff514dc9c,
title = "Single photon-emission computed tomography imaging in early Parkinson's disease",
abstract = "Current diagnostic criteria for Parkinson's disease (PD) rely on the presence of motor signs, but it is now evident that they require months or years to become clinically manifest. By contrast, initial manifestations of PD may involve several nonmotor domains, such as cognition, mood, smell or sleep, and their recognition is critical if one is aiming for early diagnosis to provide neuroprotection. In this context, imaging tracers are gaining relevance as they are increasingly recognized as biological markers of disease progression. In this review, we will discuss the role of single photon-emission computed tomography imaging in the early phases of PD and in the differential diagnosis of essential tremor and atypical parkinsonism. We will also discuss the role of imaging of monoaminergic nondopamine systems to assess nonmotor features.",
keywords = "Dopamine transporter, Essential tremor, Parkinson's disease, Perfusion tracer, SPECT",
author = "Angelo Antonini and Isaias, {Ioannis U.}",
year = "2008",
month = "12",
doi = "10.1586/14737175.8.12.1853",
language = "English",
volume = "8",
pages = "1853--1864",
journal = "Expert Review of Neurotherapeutics",
issn = "1473-7175",
publisher = "Expert Reviews Ltd.",
number = "12",

}

TY - JOUR

T1 - Single photon-emission computed tomography imaging in early Parkinson's disease

AU - Antonini, Angelo

AU - Isaias, Ioannis U.

PY - 2008/12

Y1 - 2008/12

N2 - Current diagnostic criteria for Parkinson's disease (PD) rely on the presence of motor signs, but it is now evident that they require months or years to become clinically manifest. By contrast, initial manifestations of PD may involve several nonmotor domains, such as cognition, mood, smell or sleep, and their recognition is critical if one is aiming for early diagnosis to provide neuroprotection. In this context, imaging tracers are gaining relevance as they are increasingly recognized as biological markers of disease progression. In this review, we will discuss the role of single photon-emission computed tomography imaging in the early phases of PD and in the differential diagnosis of essential tremor and atypical parkinsonism. We will also discuss the role of imaging of monoaminergic nondopamine systems to assess nonmotor features.

AB - Current diagnostic criteria for Parkinson's disease (PD) rely on the presence of motor signs, but it is now evident that they require months or years to become clinically manifest. By contrast, initial manifestations of PD may involve several nonmotor domains, such as cognition, mood, smell or sleep, and their recognition is critical if one is aiming for early diagnosis to provide neuroprotection. In this context, imaging tracers are gaining relevance as they are increasingly recognized as biological markers of disease progression. In this review, we will discuss the role of single photon-emission computed tomography imaging in the early phases of PD and in the differential diagnosis of essential tremor and atypical parkinsonism. We will also discuss the role of imaging of monoaminergic nondopamine systems to assess nonmotor features.

KW - Dopamine transporter

KW - Essential tremor

KW - Parkinson's disease

KW - Perfusion tracer

KW - SPECT

UR - http://www.scopus.com/inward/record.url?scp=57749182221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57749182221&partnerID=8YFLogxK

U2 - 10.1586/14737175.8.12.1853

DO - 10.1586/14737175.8.12.1853

M3 - Article

C2 - 19086881

AN - SCOPUS:57749182221

VL - 8

SP - 1853

EP - 1864

JO - Expert Review of Neurotherapeutics

JF - Expert Review of Neurotherapeutics

SN - 1473-7175

IS - 12

ER -